Company: PHR
Filing Date: 2025-05-14
Form Type: DEF 14A
Source: 0001412408-25-000027
Chunk: 38

Company: Phreesia, Inc.
Filing Date: 2025-05-14
Form: DEF 14A
Chunk 38
---
 |     |   Total 
     ($) |
| Michael Weintraub(3)         |     |                         187,500(4) |     |             184,997 |     | 372,497 |
| Gillian Munson(5)            |     |                             72,452 |     |             184,997 |     | 257,449 |
| Mark Smith, M.D.(6)          |     |                             51,667 |     |             184,997 |     | 236,664 |
| Lainie Goldstein(7)          |     |                             49,952 |     |             184,997 |     | 234,949 |
| Ramin Sayar(8)               |     |                             49,167 |     |             184,997 |     | 234,164 |
| Edward Cahill(9)             |     |                             47,452 |     |             184,997 |     | 232,449 |
| Lisa Egbuonu-Davis, M.D.(10) |     |                             44,167 |     |             184,997 |     | 229,164 |

_______________________

(1) The amounts reported represent the annual cash retainer amounts and committee fees earned by each of our non-employee directors during the fiscal year ended January 31, 2025 pursuant to our Policy. Mr. Cahill, Ms. Munson, and Ms. Goldstein elected to receive their annual cash Board retainer of $39,952 in DSUs.

(2) The amounts reported represent the aggregate grant date fair value of the RSUs and DSUs granted during fiscal year ended January 31, 2025, as computed in accordance with FASB ASC Topic 718. For additional information about these awards, see notes 3(w) and 8 to our audited consolidated financial statements included in our 2025 Annual Report. The amounts reported in this column reflect the accounting cost for these awards and do not correspond to the actual economic value that may be received by the director upon vesting, settlement, or sale of any of the underlying shares of our common stock.

(3) As of January 31, 2025, Mr. Weintraub held (i) 180,537 shares of common stock, (ii) options to purchase 30,540 shares of our common stock, (iii) 8,490 RSUs, and